Market Indices
Sector Heatmap
GLP — Global Partners LP
NYSEGlobal Partners LP
- O
- 46.00
- H
- 47.45
- L
- 46.00
- V
- 24.16K
GLP — Latest News & Headlines
20 StoriesShould Value Investors Buy Global Partners (GLP) Stock? - finance.yahoo.com
Should Value Investors Buy Global Partners (GLP) Stock? finance.yahoo.com
5 Best GLP-1 Stocks for 2026 and How to Invest - The Motley Fool
5 Best GLP-1 Stocks for 2026 and How to Invest The Motley Fool
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s - CNBC
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s CNBC
Global Partners (GLP) Cools After Recent Pullback, Is The Stock Still Cheap? - Simply Wall Street
Global Partners (GLP) Cools After Recent Pullback, Is The Stock Still Cheap? Simply Wall Street
What GLP-1 users should know about the potential risk of a rare type of vision loss - ABC News - Breaking News, Latest News and Videos
What GLP-1 users should know about the potential risk of a rare type of vision loss ABC News - Breaking News, Latest News and Videos
Zealand's stock slides as Boehringer-partnered obesity drug underwhelms again in phase 3 - Fierce Biotech
Zealand's stock slides as Boehringer-partnered obesity drug underwhelms again in phase 3 Fierce Biotech
GLP-1 users report more nail detachment, hair loss than nonusers, study finds - Medical Economics
GLP-1 users report more nail detachment, hair loss than nonusers, study finds Medical Economics
How the GLP-1 Boom Stress-Tests the Pharma Cold Chain - Pharmaceutical Commerce
How the GLP-1 Boom Stress-Tests the Pharma Cold Chain Pharmaceutical Commerce
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote - AJMC
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote AJMC
Global Partners (NYSE:GLP) Shares Pass Above 200-Day Moving Average - Should You Sell? - MarketBeat
Global Partners (NYSE:GLP) Shares Pass Above 200-Day Moving Average - Should You Sell? MarketBeat
Global Partners (GLP) Could Be 58% Undervalued On Its Cash Flow View - finance.yahoo.com
Global Partners (GLP) Could Be 58% Undervalued On Its Cash Flow View finance.yahoo.com
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly? - The Motley Fool
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly? The Motley Fool
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production - CNBC
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production CNBC
PepsiCo (PEP) Stock May Be 22% Undervalued On GLP 1 Risk - Simply Wall Street
PepsiCo (PEP) Stock May Be 22% Undervalued On GLP 1 Risk Simply Wall Street
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly? - finance.yahoo.com
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly? finance.yahoo.com
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy? - The Motley Fool
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy? The Motley Fool
VKTX Stock Soars as Viking Therapeutics Announces Positive GLP-1 Trial Results - finance.yahoo.com
VKTX Stock Soars as Viking Therapeutics Announces Positive GLP-1 Trial Results finance.yahoo.com
McDonald's is spending $8.5 billion to overhaul its menu for the GLP-1 era — and shares dropped 6% on the news - finance.yahoo.com
McDonald's is spending $8.5 billion to overhaul its menu for the GLP-1 era — and shares dropped 6% on the news finance.yahoo.com
Novo Nordisk Stock Slides After Unveiling Long Term Pipeline Growth Targets - finance.yahoo.com
Novo Nordisk Stock Slides After Unveiling Long Term Pipeline Growth Targets finance.yahoo.com
Will GLP-1s hurt food stocks? Assessing the changing consumer. - finance.yahoo.com
Will GLP-1s hurt food stocks? Assessing the changing consumer. finance.yahoo.com